Medical cannabis policy and practice in Germany
Dr Franjo Grotenhermen tells MCN about medical cannabis policy and practice in Germany.
Doctor, author and cannabis advocate Dr Franjo Grotenhermen is founder and Executive...
Medical cannabis treatment in the UK with Professor Mike Barnes
Medical cannabis expert Professor Mike Barnes discusses Medical cannabis treatment and highlights the challenges facing cannabis in the UK.
Consultant neurologist and medical cannabis treatment...
Quality control and analysis in medical cannabis production
MCN speaks to independent consulting firm NNE about how quality control, testing, and analysis in medical cannabis production can benefit patients.
Independent consultancy NNE operates...
Engineering environmental controls for efficient indoor cultivation
Grow2Guys offers lessons from North America for European indoor cultivation facilities.
Grow2Guys, a division of urban-gro, Inc, has provided full-service mechanical, electrical, and plumbing (MEP)...
Sanity Group: unlocking the health benefits of cannabinoid medicines
Sanity Group puts people first to improve patient access and drive innovation, and utilises the health benefits of cannabinoid medicines.
Putting people first, as well...
The CryoEXS Advantage: industrial extraction technology for cannabis
Explore the benefits of investing in the latest industrial scale extraction technology for cannabis processing facilities - CryoEXS extraction systems.
Root Sciences established one of...
Free medical cannabis education platform launched in the UK
A free medical cannabis education platform has been launched by Sapphire Medical Clinics in response to a recommendation by The National Institute for Health...
Education, development, and campaigning for patient access to medical cannabis
Althea’s mission is to alleviate the suffering of patients with debilitating conditions through education, development, and campaigning for patient access to medical cannabis.
The primary...
Meet Khiron: the company providing cannabis trials with medical products
Khiron Life Sciences is a cannabis pharmaceuticals company with operations and a presence across Latin America, joint venture entry into the US consumer market,...
Cloud 9: high quality standards for hemp and cannabis products
Cloud 9 Group leverages its strong principles and high quality standards to produce premium hemp and cannabis products.
The Cloud 9 Group of private companies...
EUMCA calls for reduction of lower THC limit in German cannabis extracts
The European Medical Cannabis Association (EUMCA) is calling for the reduction of the lower THC limit in cannabis extracts from 1% to 0.2% to...
Exploring growth in the European medical cannabis market
Luc Springinsfeld of leading investment bank Bryan, Garnier & Co explores the European medical cannabis market and the rise of medical cannabis investment in...
Patient access to cannabis in the UK: Cellen breaks down barriers
Unfortunately, it remains challenging for UK patients to access medical cannabis – but rapidly expanding provider Cellen Therapeutics is working to break down those...
Khiron Life Sciences: expanding into Europe with patient focus
Global cannabis leader Khiron Life Sciences is expanding into the European sector with a patient focus.
Khiron Life Sciences is a vertically integrated global cannabis...
The wellness revolution with Medicaleaf
A coronavirus ‘good news’ story from innovator Medicaleaf, looking at the wellness revolution.
When a group of relative strangers with myriad strengths, experience and expertise...
Malta’s COVID-19 response secures cannabis industry growth
Malta Enterprise has played a pivotal role in ensuring support for research and industry in the face of the COVID-19 epidemic. It says Malta's...
Vitality Hemp: greener home living with British hemp
British company Vitality Hemp is working to embrace the environmental and economic potential of the hemp industry.
The British hemp industry is expanding into a...
Medical cannabis patients use fewer healthcare resources
A new study has revealed that medical cannabis patients use fewer healthcare resources and report improved quality of life.
To date, there has been minimal...
Increased European cannabis demand amidst COVID-19 pandemic
MCN’s partner New Frontier Data explores the effect of COVID-19 European cannabis demand, including consumer trends and the economic future.
Despite inevitable regulatory delays due...
BBS grows as Australia becomes the new leader in medicinal cannabis
CEO John Dagas is optimistic about the medicinal cannabis market growth in Australia and the positioning of BBS to be a leader in Oceania.
Although...
